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Objectives. To describe the characteristics of patients reported with
acute flaccid paralysis between 1997 and 2002, and to evaluate the
performance of the acute flaccid paralysis surveillance system using
indicators recommended by the World Health Organization.
Design. Retrospective study.
Setting. Department of Health, Hong Kong.
Participants. Children aged younger than 15 years who were reported to
the Department of Health between 1997 and 2002 with acute flaccid paralysis.
Results. Of 120 children with acute flaccid paralysis reported between
1997 and 2002, 42% were younger than 5 years of age. None of the cases
were acute poliomyelitis or polio-compatible. A neurological cause was
identified in 67.5% of cases, of which the most common was Guillain-
Barré syndrome (42%), followed by transverse myelitis (15%). All except
one of the performance indicators consistently met World Health
Organization requirements and thus demonstrated the effectiveness
of the acute flaccid paralysis surveillance programme. The acute
flaccid paralysis notification rate consistently exceeded 1.0 per 100 000
population below 15 years of age. The requirement for adequate
stool investigation was the single indicator that did not satisfy World
Health Organization requirements. This highlighted the importance of
maintaining physicians’ awareness of acute flaccid paralysis surveillance.
Conclusion. Hong Kong should remain vigilant for acute flaccid paralysis.
The effective surveillance system and its evaluation may serve as a model
for surveillance of other infectious diseases.
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Introduction
Poliomyelitis (polio) is a highly infectious disease
caused by the poliovirus. It affects mainly children
under 5 years of age and causes paralysis in one of
every 200 to 1000 infections.1,2 Poliomyelitis has been
a statutory notifiable infectious disease in Hong Kong
since 1948,3 with peak incidences reported in 1958 and
1962 (262 and 363 cases; incidence rate, 9.2 and 11.0
per 100 000 population, respectively). The last case of
poliomyelitis was reported in 1983. The last vaccine-
associated case of poliomyelitis occurred in 1995, but
was not notified until August 2000.
Polio eradication is achieved through intensive
immunisation, vigilant surveillance for acute flaccid
paralysis (AFP), and laboratory containment.4
According to the World Health Organization (WHO),
certifying a country as polio-free requires that there
are no reports of new cases caused by the indigenous
wild poliovirus for a period of at least 3 consecutive
years under the conditions of high-quality surveillance
for polio.4-6 Hong Kong is part of the WHO Western
Pacific region and was certified polio-free in October
2000.7 In the post-certification period, it is vital to
maintain effective and sensitive surveillance for
AFP so that any importation of wild poliovirus, or
inadvertent introduction of wild poliovirus from
failure of laboratory containment is detected.8-10 In
the past, the use of the oral polio vaccine had been
associated with emergence of vaccine-derived
poliovirus (VDPV) that caused outbreaks of disease
in areas with poor vaccine coverage.10-12 Recent bio-
terrorist attacks have also highlighted the need to detect
poliovirus being used as a biological weapon.
Acute flaccid paralysis surveillance should involve
detecting, reporting, and investigating suspected cases,
collecting and analysing data from reporting sites, as
well as reporting the findings to clinicians, field
investigators, and interested parties.6 In 1997, the
surveillance in Hong Kong began.7 The National
Committee for the Certification (NCC) of Wild
Poliovirus Eradication, comprising paediatricians, gov-
ernment officials, and epidemiologists, was set up to
oversee the certification process and, later, to provide
strategic advice for maintaining vigilant surveillance
and monitoring performance. The NCC communicates
directly with the WHO with regard to AFP surveillance
and receives secretariat support from the Depart-
ment of Health (DH) of the Hong Kong Special
Administrative Region Government.
A paediatrician has been identified as the ‘key
physician’ in each of the 14 public hospitals in Hong
Kong. His/her remit is to ensure that cases of AFP
are promptly identified and reported, and to submit nil
returns to the DH on a monthly basis (‘zero-case
reporting’): this serves to distinguish zero-reporting
from non-reporting. The NCC also solicits support
from doctors in the private medical sector who are
members of the Hong Kong Society of Child
Neurology and Developmental Paediatrics, and the
Hong Kong College of Paediatricians.
Virological testing for poliovirus is performed
by the Public Health Laboratory Service Branch
(PHLSB) of the Centre for Health Protection under
the DH, and is accredited by WHO. To encourage all
clinicians to adequately investigate cases of AFP, there
is no charge for the virological-testing service. The
statistics on performance indicators were disseminated
to all reporting ‘key physicians’ and other stakeholders
on an annual basis.
The WHO has devised a set of performance
indicators to ensure that AFP surveillance is properly
maintained. Unlike many countries, the results of the
surveillance system in Hong Kong have not been
published.13,14 This paper summarises the AFP
surveillance findings from 1997 to 2002, evaluates
the system, and identifies aspects that require
improvement.
Methods
The WHO defines AFP as “any child under fifteen
years of age with acute flaccid paralysis (including
Guillain-Barré syndrome)”.15 From 1997 to 2002, all
cases that fulfilled the WHO definition were included
in this study. All AFP notifications received by the DH
were subjected to full epidemiological and laboratory
investigations. Field investigations were initiated
within 24 hours of notification. The WHO guidelines
require that two ‘adequate’ stool samples be collected
within 14 days of onset of paralysis.15 Contacts of
the patient were traced to ensure that they had been
fully immunised. All cases were evaluated 60 days
following onset of symptoms to identify signs of
residual weakness. Investigation results including
demographics, dates of investigations, diagnosis
and follow-up, and laboratory findings were collated.
The data were analysed to generate statistics
based on the WHO performance indicators. Statistical
Package for the Social Sciences (Windows version
10.0; SPSS Inc., Chicago [IL], United States) was used
for analysis.
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The NCC has formed an Expert Panel of four
consultant paediatricians who are responsible for the
classification of AFP cases according to WHO
recommendations. The WHO protocol for case
classification (Fig 1) was followed to determine which
cases should undergo Expert Panel review. This in-
cluded patients whose stool specimens were in-
sufficient for laboratory diagnosis, who yet suffered
from residual weakness, or who had not been followed
up. A detailed case report was given to each panel
member who independently evaluated each case. Panel
members’ views and comments were documented and
a consensus was reached for the final classification of
each case.
Results
A total of 120 cases of AFP (73 male and 47 female)
aged from 1 month to 14 years were reported between
1997 and 2002. Those below 5 years of age accounted
for the largest proportion (42%) of cases (Fig 2).
None of the cases were classified as acute polio-
myelitis or polio-compatible. A variety of causes were
identified: neurological (67.5%), musculoskeletal
(8.3%), psychiatric (7.5%), cardiovascular (5.8%),
miscellaneous (including Kawasaki’s disease, leg-
length discrepancy, etc) [3.3%]. The cause was undeter-
mined in 7.5% of cases. The most common neuro-
logical diagnosis was Guillain-Barré syndrome (42%),
followed by transverse myelitis (15%) [Fig 3].
The peak incidences of AFP occurred in the months
of June (17 cases) and August (18 cases), coincident
with higher enterovirus activity associated with the
summer months (Fig 4). Most children had an
uneventful recovery, but 13 (11%) presented with
Fig 1. Virological flowchart and case classifications*
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residual weakness. One child with transverse myelitis
died.
Cases from 1997 to 2002 were classified according
to the virological flowchart (Fig 1). Stool examination
was adequate in 71 cases and thus able to exclude the
diagnosis of poliomyelitis. The Expert Panel reviewed
six cases: all were classified as non-polio.
Public hospitals were the source of 93% of the
notifications, whereas private hospitals for the re-
maining 7% (consistent with this, public hospitals
were responsible for 93% of total hospital admissions
in Hong Kong). No notifications were received from
private clinics, presumably because of the acute nature
of the illness that led patients to present directly or to
be immediately referred to hospital.
Fig 3. Neurological and psychiatric diagnoses of acute flaccid paralysis (AFP) cases reported from 1997 to 2002
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Fig 2. Age distribution of acute flaccid paralysis (AFP) cases reported to surveillance system from 1997 to 2002
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Stool examination in 17 cases revealed cox-
sackieviruses and adenoviruses as the most commonly
isolated pathogens.
Evaluation of acute flaccid paralysis surveillance
The performance of a surveillance system can be
judged using a series of qualitative (eg acceptability,
flexibility, and simplicity) and quantitative attri-
butes (eg sensitivity, timeliness, representativeness,
positive predictive value, and costs and usefulness of
the system).16-18 Evaluation of AFP surveillance
was based on the WHO-recommended indicators.5,6
Qualitative attributes
Acute flaccid paralysis surveillance was integrated into
the secondary health care system by means of the ‘key
physician’ network. The system consists of a simple
diagnostic algorithm for case classification as defined
by WHO (Fig 1). All physicians were made aware of
the system in order to avoid diagnostic confusion.
Integration of laboratory and epidemiological findings
was also possible.
The AFP surveillance is also flexible and robust:
objectives can be expanded from merely certifying
polio-free cases to including detection of imported
cases of poliovirus and VDPV.10,12
Since the introduction of the ‘key physician zero-
reporting’ system in 1997, more than 80% of the
reporting hospitals have been able to provide reports
on time. The acceptability of the surveillance system
to patients and their families can be measured to some
extent by their response to clinical and epidemiological
investigations. Since 1997, questionnaires have been
completed for all of the cases referred from hospitals.
Surveys of user acceptance have not been con-
ducted, but no complaints have been made about the
procedures or the nature of information sought.
Quantitative attributes
1. Ability to identify all cases of AFP
The proportion of cases detected by a surveillance
system is affected by several factors: the likelihood
that the disease requires medical attention and is
correctly diagnosed; the availability of a diagnostic
test; and the chance that the case is then reported
to the surveillance system.16 A case of paediatric
AFP should come to the attention of the health
care system because of the severity of the
condition. The WHO defined completeness of
reporting as “documentation of the timely receipt
of >80% of expected routine AFP surveillance
reports, including zero reporting where no AFP
cases were seen. The distribution of reporting sites
should be representative of the geography and
demography of the country.”15 Between 1997 and
2002, 87% to 98% of the surveillance sites for
Fig 4. No. of acute flaccid paralysis (AFP) cases reported by month from 1997 to 2002
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routine or zero-reporting submitted timely reports.
All AFP cases notified to the DH were investigated
and were followed up at 60 days. This satisfied
the requirement for completeness of investigations
and follow-up (Table 1). Although completeness
of AFP reporting was supported by availability
of both passive and active surveillance, retro-
spective reviews of hospital records were not carried
out routinely. Such reviews may reduce under-
reporting and raise public awareness.13,14,19
2. Sensitivity and positive predictive value
The WHO defined the target of at least one AFP
case per 100 000 in children under 15 years per
year as a proxy of the sensitivity of AFP
surveillance.15 This target was consistently
achieved from 1997 to 2002—between 1.3 and
2.4 per 100 000 population. Despite this, the trend
of AFP notification has been slowly declining
(Table 1).
Assessment of the sensitivity of the surveillance
system ideally requires information on the
true occurrence of AFP in Hong Kong that can
then be compared with the rates reported by the
surveillance system. As the diagnosis of AFP is
made entirely on clinical grounds, a two-source
capture-recapture method can be used to estimate
the incidence of AFP cases and to evaluate case
ascertainment with respect to the data in routine
surveillance system.19,20 This estimation method
has been employed in epidemiological studies of
the incidence and/or prevalence of a given disease
or injury as well as in evaluating the completeness
of case ascertainment. It compares two or more
independent lists of cases in order to estimate the
total number of cases in a given population, for
example, primary ascertainment source of a
national register of AFP cases compared with a
secondary data source of hospital discharge
records. A statistical model can be applied based
on the number of cases that is ascertained by
either or both sources, or that is not ascertained
by both sources. In Hong Kong, limited resources
prevented the introduction of a second case
ascertainment source (eg retrospective review of
hospital discharge records).
Similarly, the positive predictive value (PPV) of
AFP surveillance requires information on ‘true’
outcomes, that is, ‘true AFP’ cases. As the criteria
required for diagnosis are entirely symptom-based,
the number of reported cases that are incorrectly
labelled as AFP is difficult to ascertain. A
retrospective search of field investigation notes
found no incorrect reporting between 1997 and
2002, thus PPV was estimated to be close to 100%.
The capture-recapture method to estimate the
Table 1.   Performance of acute flaccid paralysis (AFP) surveillance in Hong Kong, 1997-2002
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current annual incidence of AFP could not be
applied because of the absence of hospital policy
to support retrospective review of hospital records
for AFP. In addition, the capture-recapture method
presumes a stable population. This cannot be
presumed in Hong Kong because of continuous
inflow of immigrants from Mainland China. The
capture-recapture method also assumes that
the two ascertainment sources are independent
of each other.19,20 Again this is not the case in
Hong Kong: both routine surveillance systems
rely on notification by paediatricians via the
‘key physician’ network and reporting hospital
discharge data are also their responsibility. The
two sources are thus positively dependent.21
3 Representativeness
The AFP surveillance network covered 14 public
hospitals across the whole territory. Almost all
(93%) hospital admissions were to public
hospitals, thus most cases of AFP were captured
by the ‘key physician’ surveillance system. The
remaining cases admitted to the private hospitals
were detected by laboratory surveillance
because all poliovirus testing was performed
by the PHLSB for free. Underreporting could
nonetheless still occur if insufficient clinical
information was entered on laboratory forms that
then evaded laboratory surveillance.
4 Timeliness
Timely reporting of an infectious disease is vital
to public health if specific action is required to
prevent transmission of infection.16,17 The timely
detection and reporting of a single case reflects
the response of the public-health system to an
outbreak and its ability to deal with an emergency.
Surveillance of AFP in Hong Kong satisfied
WHO requirements (>80%) on all indicators of
timeliness (Table 2): all of the notified AFP cases
were investigated within 48 hours of notification
and followed up 60 days from onset. The system
scored less well on the performance indicator that
required ‘adequate stool specimen’ from more than
80% of AFP cases: 1997 (36%), 1998 (74%), 1999
(80%), 2000 (61%), 2001 (56%) and 2002 (60%)
[Table 1].
Between 1997 and 2002, specific phone enquiries
were made to the paediatrician in charge of each
of the 47 cases without adequate stool examination
to establish the reason for not meeting WHO
requirement. In most instances, this was due to
delayed or improper collection of samples,
because of the lack of awareness of the attending
physician.
5 Costs
The WHO has estimated that between 1988 and
2005, 5 million people worldwide who would
otherwise have been paralysed were able to
walk because of the Global Polio Eradication
Initiative.22 Without eradication of the disease,
the costs would have been enormous: most of
those affected would have been children who
would have required hospitalisation and suf-
fered long-term neurological disabilities.
Additional costs would arise from absenteeism
from work and school. Surveillance of AFP
has been integrated into the routine health care
system without incurring extra costs. It thus
provides a cost-effective means of preventing
the disastrous sequelae of poliomyelitis through
early detection.
6 Usefulness of the system
The usefulness of the system can be judged by
how well it supports public health policies and
interventions related to eradication and prevention
of poliomyelitis. Since its inception, AFP
surveillance has resulted in the documentation and
subsequent certification of Hong Kong as polio-
free. The system continues to fulfill most attributes
Table 2.  Indicators of timeliness
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requested by WHO in proving that Hong Kong
remains polio-free. The WHO has praised the
system in Hong Kong and has recommended that
the current network be used as a model for
surveillance of other infectious diseases and their
ultimate elimination, such as measles.23,24
7 Quality of laboratory surveillance
Laboratory performance is critical to AFP
surveillance. The PHLSB has satisfied the
performance requirements of the WHO for
poliovirus diagnosis and characterisation in
terms of average annual score and specimen
submission (Table 1). All polio and non-polio
enterovirus isolates were typed and results
reported within 28 days. The laboratory has
acquired both antigenic and molecular techniques
for intra-typic differentiation as well as nucleotide
sequencing so that all poliovirus isolates from AFP
and non-AFP cases can be tested in a timely
manner to exclude non–Sabin-like poliovirus. In
2000, laboratory surveillance was sufficiently
sensitive to isolate an immunodeficient excretor
of VDPV from a routine stool sample taken from
an immunocompromised infant.
Discussion
Importation of poliovirus into Hong Kong remains
a threat. It is vital to continue surveillance for
AFP in children younger than 15 years. Guillain-Barré
syndrome was the most common cause of AFP cases
in Hong Kong, consistent with the findings of other
countries.19 This syndrome occurs throughout the
world with a median annual incidence of 1.3 cases
per 100 000 population.25,26 No published data are
available on the incidence of Guillain-Barré syndrome
in Hong Kong, but AFP surveillance data suggest
that around six cases per year will be diagnosed
with paralytic presentations. Extrapolation of these
data based on the 2002 population in Hong Kong
gives an incidence of 0.6 per 100 000 population
under 15 years of age. Thus the WHO global sensi-
tivity indicator for AFP, which was affected largely
by Guillain-Barré syndrome incidence, appears to
overestimate the incidence in Hong Kong.
The number of reported cases was comparatively
higher during the summer months due to higher
enterovirus activity. Raising physicians’ awareness by
reminders and publicity campaigns may help capture
cases of AFP during this period. Because of the wide
range of diagnoses assigned to children presented with
AFP, paediatricians in different subspecialties, with
the exception of neurologists, need to be reminded to
report any suspicious case. Mandatory protocols or
incorporating data fields into standard records should
be considered.
A successful AFP surveillance programme depends
on three factors: detection, investigation, and reporting
of cases. Results from the AFP surveillance programme
revealed that vigilance in case detection and reporting
achieved international targets. Nonetheless, the
reduction in notifications from 1997 (2.4/100 000
population below the age of 15 years) to 2001 (1.5)
suggests a decline in the enthusiasm to report. This
appears to have been due to a decline in physicians’
awareness, as evidenced by a rebound in reporting
rates to 1.8 per 100 000 population below 15 years of
age in 2002 following repeated reminder letters to ‘key
physicians’ and their paediatric departments, as well
as personal contacts. Although the WHO takes this as
a proxy indicator for sensitivity of the system, this study
is limited by the lack of retrospective hospital discharge
record reviews to cross-validate the known results. This
shortfall can nonetheless be compensated by two
factors: the acute nature of AFP that necessitates
hospital admission for most cases and the existence of
active surveillance by ‘zero-reporting’. The assessment
of completeness of reporting can be further improved
by reviewing hospital discharge records as secondary
data sources.
Physicians in clinical and public health systems
demonstrated a timely response in routine reporting,
investigations, and follow-up. The proportion of
adequate stool investigation remained significantly
lower than the WHO’s targeted rate of 80%, although
an exception occurred in 1999. There is clearly a need
to increase physicians’ awareness of the importance
of timely adequate stool investigation. Clinical
guidelines and standardised protocols help improve
physicians’ practice including diagnosis. Clinical
audit to enhance compliance with guidelines should
also be introduced.27-29
Since 2000, polio outbreaks caused by circulating
VDPVs in Haiti, Madagascar, and the Philippines have
conclusively demonstrated that the continued use of
the oral polio vaccine (OPV) for routine immunisation
may compromise the goal of eradicating all paralytic
disease caused by circulating polioviruses.30,31 The
WHO estimates that the risks of polio paralysis from
continued use of the OPV and consequent circulating
VDPVs is about 10 cases per year. The identification
of VDPV in Hong Kong consistently highlights the
importance of maintaining vigilance for AFP and the
Lam et al
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possible need to use inactivated polio vaccine (IPV)
instead of OPV in the post-certification period. The
WHO recommends that to minimise the long-term risks
associated with OPV, the routine use of OPV should
cease as soon as possible after global eradication, while
surveillance sensitivity and population immunity
remains high. Universal introduction of IPV is not
currently advocated as the WHO has not determined
that under what conditions the use of OPV can be safely
ceased.
The AFP surveillance system in Hong Kong
compares well with many other systems in the Western
Pacific region.23,24 The WHO recommends that a pro-
gramme to eliminate measles should start with a surveil-
lance network modelled on which exists for AFP.23
Conclusion
Hong Kong continues to support the WHO global
polio eradication initiative. Its AFP surveillance
programme meets most of the WHO requirements in
terms of epidemiological and laboratory performance.
Maintaining physicians’ awareness continues to be a
top priority along with continued vigilance in all
aspects of polio eradication, including monitoring
of polio importation and VDPV.
Infectious diseases do not respect country
borders. Hong Kong should reinforce the exchange
of epidemiological data of poliomyelitis with
neighbouring regions via WHO and the Mainland
to prevent the importation of wild poliovirus.
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